2-27053036-A-C
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBS1_Supporting
The NM_021831.6(AGBL5):āc.78A>Cā(p.Glu26Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000587 in 1,613,652 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_021831.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
AGBL5 | NM_021831.6 | c.78A>C | p.Glu26Asp | missense_variant | 2/15 | ENST00000360131.5 | NP_068603.4 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
AGBL5 | ENST00000360131.5 | c.78A>C | p.Glu26Asp | missense_variant | 2/15 | 1 | NM_021831.6 | ENSP00000353249.4 |
Frequencies
GnomAD3 genomes AF: 0.000243 AC: 37AN: 152136Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000358 AC: 90AN: 251094Hom.: 0 AF XY: 0.000457 AC XY: 62AN XY: 135704
GnomAD4 exome AF: 0.000623 AC: 911AN: 1461516Hom.: 0 Cov.: 31 AF XY: 0.000668 AC XY: 486AN XY: 727032
GnomAD4 genome AF: 0.000243 AC: 37AN: 152136Hom.: 0 Cov.: 33 AF XY: 0.000283 AC XY: 21AN XY: 74312
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 16, 2022 | This sequence change replaces glutamic acid, which is acidic and polar, with aspartic acid, which is acidic and polar, at codon 26 of the AGBL5 protein (p.Glu26Asp). This variant is present in population databases (rs140434382, gnomAD 0.07%). This variant has not been reported in the literature in individuals affected with AGBL5-related conditions. ClinVar contains an entry for this variant (Variation ID: 853560). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The aspartic acid amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Retinal dystrophy Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Institute of Human Genetics, Univ. Regensburg, Univ. Regensburg | Jan 01, 2022 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at